Clinical observation on treatment with the kidney-tonifying prescription in 25 cases of postmenopausal osteoporosis.
To observe the therapeutic effects of the kidney-tonifying prescription in the treatment of postmenopausal osteoporosis (PMOP), 45 cases of PMOP were selected and randomly divided into two groups, the treatment group treated with the kidney-tonifying prescription and routine western drugs, and the control group treated with routine western drugs. After a 8-month treatment, the total effective rate of the treatment group reached 96%, obviously superior to that of the control group (50%, P < 0.05); and the level of estradiol and bone mineral density (BMD) had obviously been increased (P < 0.05). The kidney-tonifying prescription has the effects of improving the clinical symptoms, and increasing the level of estrin and BMD.